FDA Adverse Event Other Summary report: N

COAPTITE INJECTABLE IMPLANT

MDR report key: 3429644 · Received October 17, 2013

Report

Report Number
2135225-2013-00141
Event Type
Other
Date Received
October 17, 2013
Date of Event
October 9, 2012
Report Date
September 29, 2015
Manufacturer
MERZ NORTH AMERICA, INC.
Product Code
LNM
PMA / PMN Number
P040047
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE HISTORY RECORDS FOR LOT 1033553 WERE REVIEWED, ALL REQUIRED TESTING SPECIFICATIONS WERE MET PRIOR TO RELEASE, THERE WERE NO ABNORMALITIES NOTED.

Additional Manufacturer Narrative · 1

THE DEVICE HISTORY RECORDS FOR THE REPORTED LOT WERE REVIEWED. ALL REQUIRED TESTING SPECIFICATIONS WERE MET PRIOR TO RELEASE. THERE WERE NO ABNORMALITIES NOTED.

Description of Event or Problem · 1

A PATIENT ((B)(6)) WAS ENROLLED IN THE POST-APPROVAL COAPTITE INJECTABLE IMPLANT STUDY FOR STRESS URINARY INCONTINENCE. ON (B)(6) 2012 THE PATIENT WAS INJECTED WITH 2.0 ML COAPTITE, LOT 1033553. ON (B)(6) 2012, THE PATIENT DEVELOPED URINARY RETENTION DIAGNOSED BY A BLADDER SCAN. THE PATIENT WAS TREATED WITH FOLEY CATHETERIZATION STARTING ON (B)(6) 2012. THE ADVERSE EVENT RESOLVED ON (B)(6) 2012. PER PHYSICIAN, THE EVENT WAS OF MILD SEVERITY AND DEFINITELY RELATED TO COAPTITE.

Description of Event or Problem · 1

THE PATIENT WAS ENROLLED IN THE (B)(4) STUDY FOR STRESS URINARY INCONTINENCE. ON (B)(6) 2012 THE PATIENT WAS INJECTED WITH 2.0ML OF COAPTITE, LOT 1033926. ON (B)(6) 2012 THE PATIENT REPORTED A URINARY TRACT INFECTION. ON (B)(6) 2012 THE PATIENT WAS PRESCRIBED MACROBID (DOSE & DURATION NOT PROVIDED). AS OF (B)(6) 2012 THE EVENT WAS RESOLVED AND THE PATIENT WAS INJECTED WITH 2.0ML OF COAPTITE. THE PHYSICIAN ASSESSED THE CASE AS MILD AND DEFINITELY NOT DEVICE RELATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
533614 COAPTITE INJECTABLE IMPLANT INJECTABLE IMPLANT LNM MERZ NORTH AMERICA, INC. 1033926

Patients

Seq Age Sex Outcome Treatment
1 88 YR Required Intervention